TimeScale Financial’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

TimeScale Financial’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100	Closed	-$1.76K	–	676
2022 Q4	$1.76K	Hold	100	–	–	﹤0.01%	471
2022 Q3	$2K	Buy	+100	New	+$1.74K	﹤0.01%	477

TimeScale Financial's ZEAL Position: Q1 2023 in Review

TimeScale Financial sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2023, closing a stake of 100 shares — an estimated $1.76K sold.

TimeScale Financial first reported a position in ZEAL in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZEAL as of Q1 2023.

TimeScale Financial reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2023 after selling out during the quarter.
TimeScale Financial sold 100 Zealand Pharma A/S American Depositary Shares shares in Q1 2023, an estimated $1.76K.
TimeScale Financial first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2022 and held it in 2 quarters.
TimeScale Financial's Zealand Pharma A/S American Depositary Shares position peaked at $2K in Q3 2022.
0 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2023.

Based on TimeScale Financial's 13F filing for Q1 2023, filed 24 Apr 2023.